REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
23/06/2025
Voltar para busca
Dado oficial do USPTO
KRINGLE PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
KRINGLE PHARMA
ST13
US500000088573224Classe
5, 42
Pedido
88573224
Registro
6087427
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
19
Atualização mais recente
24/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
09/08/2019
Data de registro
23/06/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/06/2020
Última transação
24/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Supplemental Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
03
Localização do titular
Ibaraki-shi, Osaka, JP
Examinador
MAYES, LAURIE
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
KRINGLE PHARMA, INC.
Representantes
Sandra Epp Ryan Hamre, Schumann, Mueller & Larson, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
pharmaceutical and veterinary preparations for the treatment of liver diseasesrenal diseasenerve system diseasesskin diseasescardiovascular diseasescancer; sanitary preparations for medical use; central nervous system stimulants; hair growth stimulant; antipyretic analgesics; anti-epileptic pharmaceutical preparations; analeptics; hypnotic sedatives; general anesthetics; anti-motion sickness preparations; pharmaceutical preparations acting on the peripheral nervous system for treating solitary peripheral neuritispolyneuritis monopolypolyneuritisradial nerve palsymedian nerve palsyulnar nerve palsyperoneal nerve palsytibial nerve palsyfacial palsyBell palsyoppressive neuropathyacute intermittent porphyriachronic inflammatory demyelinating neuropathytrigeminal neuralgiadiabetic neuropathyvitamin B deficiencypellagraberiberipolyarthritis nodosasystemic lupus erythematosuscarpal tunnel syndrometarsal tunnel syndromeelbow tunnel syndromeback painallodyniapain of fingernumbness of fingerGuillain-Barre syndromeCharcot-Marie-Tooth diseaseFamilial amyloid polyneuropathyAddictive neuropathycancer neuropathyCrow-Fukase syndromePostherpetic neuralgiaPolyneuropathyPolyradiculitisNeronopathyMononeuropathyMultiple mononeuropathyPlexopathy; local anesthetics; skeletal muscle relaxants; anhidrotics; autonomics in the nature of pharmaceutical preparations for treating heart conditions; antispasmodics; diaphoretics; pharmaceutical preparations acting on the sensory organs for treating eye illnesses and conditions; ophthalmic preparations; agents for otic and nasal usenasal spray preparationsmedicated eye washeseye dropsirrigating solutions for eye use; treatment preparations for treating eye infectionmacular degenerationretinopathyrhinitissinusitis; pharmaceutical antiallergic preparations; antihistaminics; cardiovascular treatment preparations; cardiotonics; antihypertensives; vasoconstrictors; capillary stabilizerspharmaceutical preparations for stabilizing capillaries; cerebral hemorrhage prophylactic preparations; antiarrhythmic preparations; diuretics; pharmaceutical preparations acting on respiratory organs for treating respiratory illnesses and conditions; respiratory stimulants; anti-cough drops; antitussive expectorants; pharmaceutical preparations acting on digestive organs for treating ulcers and digestive conditions; gastrointestinal cleaning agents; clysters in the nature of enema preparations; evacuants being purgatives; stomachics in the nature of medicinal tonics that assist in digestion and digestives for pharmaceutical purposes; pharmaceutical preparations for oral use for preventing dental cariesfor treating and preventing oral inflammation; emetics; pharmaceutical preparations for dental purposes for treating and preventing gingivostomatitisalveolar abscessalveoloclasia; antacids; antiemetics; castor oil for medical purposes; cholagogues; hormones for medical purposes; thyroid and para-thyroid hormone preparations; mixed hormone preparations; estrogen preparations; pancreas hormone preparations; salivary gland hormone preparations; androgen preparations; pituitary hormone preparations; adrenal hormone preparations; pharmaceutical preparations acting on uro-genital and anal organs for treating urinary and anal gland related illnesses and conditions; oxytocics; anti-hemorrhoidal preparations; emmenagogues; contraceptive preparations; medicated skin care preparations; pharmaceutical preparations for treating purulence; anti-dermoinfectives; antimicrobials for dermatologic use; astringents for medical purposes; anti-inflammatory agents; analgesics; anti-itching ointment; talcum powder for medical purposes; medicated baby oils; medicated baby powders; medicated bath preparations; vitamin preparations for medical purposes; cod-liver oil drops for medical purposes; mixed vitamin preparations for medical purposes; vitamin A preparations for medical purposes; vitamin C preparations for medical purposes; vitamin D preparations for medical purposes; vitamin B preparations for medical purposes; multi-vitamin preparations for medical purposes; amino acid preparations for medical purposes; threonine preparations; tryptophane preparations; methionine preparations; lysine preparations; royal jelly for medical purposes; calcium supplements for medical purposes; chondroitin preparations for medical purposes; protein supplements and amino acid preparations for medical purposes; saccharide preparations for treating skin diseasesskin ulcerinjuryburnsclerodermadematitiserythrodermakeratosisdyschromatosislupus erhthematosus; mineral preparations for medical use; anticoagulants; blood substitutes for human and veterinary use; blood plasma; hemostatics for medical purposes; pharmaceutical preparations affecting metabolism; antidotes; enzyme preparations for medical purposes; lactagogues; lipotropic factor preparations; pharmaceutical preparations for the treatment of habitual intoxication; pharmaceutical preparations for activating cellular function; tumor suppressing agents; anti-cancer preparations; anti-sarcoma preparations; pharmaceutical preparations for treating physically caused lesions; pharmaceutical preparations for treating heatstroke; radiation sickness treating drugs; pharmaceutical preparations for treating chemically caused disordersfor treating chemical burnsside effects of anticancer drugsside effects of immunosuppresants; chlorine-detoxication preparations for medical purposes; arsenic-detoxication preparations for medical purposes; benzol-detoxication preparations for medical purposes; antibiotic preparations; erythromycin preparations; chloramphenicol preparations; colistin-polymixin preparations; sarkomycin preparations; streptomycin preparations; thiolutin preparations; tetracycline preparations; trichomycin preparations; mixed antibiotic preparations; penicillin preparations; chemotherapeutics; antisyphilitics; antituberculous preparations; sulfonamide preparations; antileprotic preparations; biological preparations for medical purposesbiological tissue grafts; antitoxic sera; antitoxins; mixed biological preparations for medical purposes for the treatment of cancer; preparations for biological tests for medical purposesmedical diagnostic reagents for testing of body fluids; toxoidsvaccines against the flu; vaccines; preparations for destroying parasites; anthelmintics; odor neutralizing preparations for use on hard surfaces that have had contact with odorous pharmaceuticals; diagnostic preparations for medical use; x-ray contrast agents; diagnostic reagents for medical use; diagnostic media for bacteriological cultures for medical use; radio isotope markers for therapeutic or diagnostic use; opium alkaloid preparations; prescription synthetic narcotics; coca alkaloid preparations; mosquito-repellent incenses; germicides and fungicides; rodenticides; insecticides; fumigants; herbicidesweedkillers; insect-repellents; antiseptics
Classe 42
Testinginspection or research of pharmaceuticals and genetics; medical research; consultancy and providing testinginspection and research information services in the field of testinginspection or research of pharmaceuticals and genetics; consultancy and providing research information services in the field of medical research; providing medical research and scientific research information and advice in the fields of pharmaceuticals and genetics
Publicações
Histórico de despachos e eventos da marca no USPTO.
19 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/05/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/05/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/05/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/05/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/05/2022
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
23/06/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
18/05/2020
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
11/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/05/2020
ALIE
ASSIGNED TO LIE
05/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/05/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/11/2019
GNRT
NON-FINAL ACTION E-MAILED
13/11/2019
CNRT
NON-FINAL ACTION WRITTEN
13/11/2019
DOCK
ASSIGNED TO EXAMINER
07/11/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/08/2019
NWAP
NEW APPLICATION ENTERED
13/08/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace KRINGLE PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.